Stay updated on Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated to v3.5.0 (replacing v3.4.3) in the record history.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page history now shows Revision: v3.4.3 as the latest update, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check54 days agoChange DetectedThe history list now includes a new revision entry: Revision: v3.4.2. The previously displayed funding-status notice and the v3.4.1 revision entry were removed.SummaryDifference0.3%

- Check61 days agoChange DetectedAdded a notice about government funding lapse and NIH operating status; updated the revision label from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check68 days agoChange DetectedGlossary display was added; the page now color-codes changes with green for additions and red for deletions, and the revision footer includes No FEAR Act Data and Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedA new revision entry v3.3.4 was added to the Record History page, replacing the earlier v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.